Explore more publications!
Middle East Consumer Products News
Got News to Share?

Middle East Consumer Products News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Consumer Products News.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on November 19, 2025

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
November 19, 2025

Zions Bancorporation Investor News: If You Have Suffered Losses in Zions Bancorporation, N.A. (NASDAQ: ZION, ZIONP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Indeterminate GlobeNewswire
Sumatra Slim Belly Tonic Represents Growing Scientific Interest in Sleep-Metabolism Connection as Research Expands Beyond Traditional Weight Management
November 19, 2025

Sumatra Slim Belly Tonic Represents Growing Scientific Interest in Sleep-Metabolism Connection as Research Expands Beyond Traditional Weight Management

Indeterminate GlobeNewswire
Nagano Tonic Emerges as Consumer Demand for Plant-Based Metabolism Support Reaches Sustained High Levels, Industry Analysis Shows
November 19, 2025

Nagano Tonic Emerges as Consumer Demand for Plant-Based Metabolism Support Reaches Sustained High Levels, Industry Analysis Shows

Indeterminate GlobeNewswire
TestClear Addresses Best THC Detox Kit Selection Confusion: Why Body Composition and Metabolism Matter More Than Ever
November 19, 2025

TestClear Addresses Best THC Detox Kit Selection Confusion: Why Body Composition and Metabolism Matter More Than Ever

Indeterminate GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Trex, United Homes Group, and Nidec and Encourages Investors to Contact the Firm
November 19, 2025

Bragar Eagel & Squire, P.C. Is Investigating Trex, United Homes Group, and Nidec and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire
Woodward Named to 2026 Forbes Best Companies List
November 19, 2025

Woodward Named to 2026 Forbes Best Companies List

Indeterminate GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Stockholders of DexCom, Synopsys, CarMax, and Fiserv to Contact the Firm Regarding Their Rights
November 19, 2025

Bragar Eagel & Squire, P.C. Urges Stockholders of DexCom, Synopsys, CarMax, and Fiserv to Contact the Firm Regarding Their Rights

Indeterminate GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
November 19, 2025

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX

Indeterminate GlobeNewswire
ROSEN, A LONGSTANDING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
November 19, 2025

ROSEN, A LONGSTANDING LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

Indeterminate GlobeNewswire
CarMax, Inc. (KMX) Class Period in Securities Class Action Expanded Amid CEO Termination – Hagens Berman
November 19, 2025

CarMax, Inc. (KMX) Class Period in Securities Class Action Expanded Amid CEO Termination – Hagens Berman

Indeterminate GlobeNewswire
TILT Holdings Gives Notice of Meeting of Junior Secured Noteholders
November 19, 2025

TILT Holdings Gives Notice of Meeting of Junior Secured Noteholders

Indeterminate GlobeNewswire
DAVIDsTEA Closes $3.0 Million Private Placement
November 19, 2025

DAVIDsTEA Closes $3.0 Million Private Placement

Indeterminate GlobeNewswire
DAVIDsTEA a procédé à la clôture d’un placement privé de 3,0 M$
November 19, 2025

DAVIDsTEA a procédé à la clôture d’un placement privé de 3,0 M$

Indeterminate GlobeNewswire
How an Emirati Entrepreneur is Changing the Way We Think About Hydration and Cola
November 19, 2025

How an Emirati Entrepreneur is Changing the Way We Think About Hydration and Cola

Indeterminate EIN Presswire
Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny -- Hagens Berman
November 19, 2025

Synopsys (SNPS) Exists Amidst Securities Class Action, IP Unit Scrutiny -- Hagens Berman

Indeterminate GlobeNewswire
AutoZone to Release First Quarter Fiscal 2026 Earnings December 9, 2025
November 19, 2025

AutoZone to Release First Quarter Fiscal 2026 Earnings December 9, 2025

Indeterminate GlobeNewswire
BlackRock® Canada Announces Estimated 2025 Annual Reinvested Capital Gains Distributions for the iShares® ETFs
November 19, 2025

BlackRock® Canada Announces Estimated 2025 Annual Reinvested Capital Gains Distributions for the iShares® ETFs

Indeterminate GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FCX
November 19, 2025

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - FCX

Indeterminate GlobeNewswire
Xcel Brands, Inc. Announces Third Quarter 2025 Financial Results
November 19, 2025

Xcel Brands, Inc. Announces Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
November 19, 2025

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions